Wide Ranks

MDWD

MediWound Ltd.

17.45

Top Statistics
Market Cap 188 M Forward PE -7.55 Revenue Growth 6.10 %
Current Ratio 1.65 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -99.17 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -9.52 Enterprise / Revenue 6.86 Price To Sales Trailing12 Months 9.35
Profitability
Profit Margins -99.17 % Operating Margins -88.56 %
Balance Sheet
Total Cash 29 M Total Cash Per Share 3.15 Total Debt 6 M
Total Debt To Equity 35.56 Current Ratio 1.65 Book Value Per Share 3.43
All Measures
Short Ratio 1859.00 % Message Board Id finmb_1570881 Fax 972 7 797 14111
Shares Short Prior Month 579421 Return On Equity -0.7566 City Yavne
Uuid 1d731941-74dc-3c53-8065-5808c744e4bc Previous Close 16.90 First Trade Date Epoch Utc 1 B
Book Value 3.43 Beta 0.8380 Total Debt 6 M
Volume 65250 Price To Book 5.09 Last Split Date 1 B
Fifty Two Week Low 8.75 Total Cash Per Share 3.15 Total Revenue 20 M
Shares Short Previous Month Date 1 B Target Median Price 27.50 Max Age 86400
Recommendation Mean 1.50 Sand P52 Week Change 0.3133 Operating Margins -88.56 %
Target Mean Price 29.00 Net Income To Common -19973000 Short Percent Of Float 0.0643
Implied Shares Outstanding 10 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 51230 Average Volume10days 51230 Total Cash 29 M
Next Fiscal Year End 1 B Revenue Per Share 2.18 Held Percent Insiders 0.1975
Ebitda Margins -72.01 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 16.90 Target Low Price 25.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 17.16 Open 16.80
Free Cashflow -8423750 Dividend Yield 0.00 % Return On Assets -0.1577
Time Zone Short Name EST Trailing Eps -2.91 Day Low 16.77
Address1 42 Hayarkon Street Shares Outstanding 10 M Price Hint 2
Target High Price 36.00 Website https://www.mediwound.com 52 Week Change 0.9519
Average Volume 41876 Forward Eps -2.22 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 150.80 % Last Split Factor 1:7
Regular Market Day High 17.62 Is_sp_500 False Profit Margins -99.17 %
Debt To Equity 35.56 Fifty Two Week High 24.00 Day High 17.62
Shares Short 593041 Regular Market Open 16.80 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 6.86 Revenue Growth 6.10 %
Shares Percent Shares Out 0.0550 Operating Cashflow -14097000 Currency USD
Time Zone Full Name America/New_York Market Cap 188 M Is_nasdaq_100 False
Zip 8122745 Quote Type EQUITY Industry Biotechnology
Long Name MediWound Ltd. Regular Market Day Low 16.77 Held Percent Institutions 0.4550
Current Price 17.45 Enterprise To Ebitda -9.52 Financial Currency USD
Current Ratio 1.65 Gross Margins 13.25 % Industry Disp Biotechnology
Number Of Analyst Opinions 4 Country Israel Float Shares 5 M
Two Hundred Day Average 16.95 Enterprise Value 138 M Price To Sales Trailing12 Months 9.35
Forward PE -7.55 Regular Market Volume 65250 Ebitda -14503000
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
MediWound Ltd.

, a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally.

It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.

The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma.

MediWound Ltd.

was incorporated in 2000 and is headquartered in Yavne, Israel.